Cargando…
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
A newly identified novel coronavirus (SARS-CoV-2) is causing pneumonia-associated respiratory syndrome across the world. Epidemiology, genomics, and pathogenesis of the SARS-CoV-2 show high homology with that of SARS-CoV. Current efforts are focusing on development of specific antiviral drugs. Thera...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098029/ https://www.ncbi.nlm.nih.gov/pubmed/32226289 http://dx.doi.org/10.7150/ijbs.45123 |